Investors can benefit from TDS' preferred shares trading below par with attractive yields and potential for price ...

Johnson & Johnson has struck a $14.6bn deal to buy neuroscience drugmaker Intra-Cellular Therapies, the US pharmaceutical ...

The J&J deal would be the biggest biotech deal in over a year and will add treatments for disorders of the central nervous ...

(Reuters) - Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular ... "These deals do not happen every day, and as a matter of fact, for us, larger deals are more ...

Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest ...

Go5G Next subscribers are finally starting to see their Hulu accounts connect to T-Mobile's "Hulu On Us" promotion.

Zeiss introduces the Secacam 3, an affordable yet feature-packed cellular trail camera designed for nature enthusiasts and ...

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday ... and long-term growth catalyst for Johnson & Johnson and offers compelling value to patients, health systems and ...

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism ...